Global /United States /Healthcare /Medical Devices /VCYT
chevron_leftBack
Veracyte, Inc. logo

Veracyte, Inc.

VCYT
NASDAQ: VCYT Delayed
31.78USD -4.9%
As of 15 June 2026, Veracyte, Inc. has a market cap of $2.54B USD, ranking #6059 globally and #1559 in the United States. It ranks #479 in the Healthcare sector, and #102 in the Medical Devices industry.
Global Rank
6059
Country Rank
1559
Sector Rank
479
Industry Rank
102
Key Stats
Market Cap
$2.54BUSD
Enterprise Value
$2.16BUSD
Revenue (TTM)
$517.15MUSD
EBITDA (TTM)
$84.4MUSD
Net Income (TTM)
$66.35MUSD
EBITDA Margin
16%
Profit Margin
13%
PE Ratio
38.8
Forward PE
19.3
PS Ratio
4.9
PB Ratio
2.0
EV/EBITDA
25.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Marc Stapley open_in_new
Employees
755
Founded
2006
IPO
30 Oct 2013
Website
veracyte.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-4.9% -5.7% 5.9% -17% -11% 0.3%

News

Loading...

VCYT Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NASDAQ
MIC: XNAS
PRIMARY
VCYT
Veracyte Inc
ISIN: US92337F1075
Shares Out.:
79.793M1 Shares Float: 77.68M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
31.78 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Veracyte, Inc.

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.

Similar Companies

Industry: Medical Devices (United States)
Name
Market Cap diff.
PE
$173.27B
7K%
25.8
$160.73B
6K%
56.7
$159.07B
6K%
25.6
DHR
$126.55B
5K%
34.7
SYK
$120.69B
5K%
38.3
$84.93B
3K%
24.5
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
MDT
$101.9B
4K%
22.2
$97.46B
84.32B EUR
4K%
36.7
7741
$61.36B
9.83T JPY
2K%
40.0
$45.47B
39.34B EUR
2K%
18.7
ALC
$36.38B
28.99B CHF
1K%
37.9
$30.09B
203.66B CNY
1K%
26.0
chevron_leftBack